On 25 February, iBio, Inc. (NYSE MKT: IBIO), announced the issue of US patent serial No. 8,962,278 titled “COMPOSITIONS AND METHODS FOR PRODUCTION OF IMMUNOGLOBULINS. On Thursday shares of iBio, Inc. (NYSEMKT:IBIO) closed at $0.84. Company’s sales growth for last 5 years was -30.10%.
On 26 February, Cerus Corporation (NASDAQ:CERS) announced Revenue for the fourth quarter of 2014 was $9.7 million, a 5% increase from the fourth quarter of 2013, and representing more than 10% growth in INTERCEPT disposable kit demand when comparing the same periods. Cerus Corporation (NASDAQ:CERS) in last trading activity fell -0.22% to close at $4.45. Company weekly performance is -16.82% while its quarterly performance stands at 4.46%. Cerus Corporation (NASDAQ:CERS) is -36.70% away from its 52 week high.
ON 3 February, Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NYSE: HASI), reported Core Earnings, a non GAAP financial measure, for the quarter ended December 31, 2014, of $7.1 million or $0.27 per share, an increase of 23% over the $0.22 per share in the same quarter last year. On last trading day Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI) increased 1.31% to close at $17.77. Its volatility for the week is 3.14% while volatility for the month is 2.21%. HASI’s sales growth for past 5 years was 34.20%. Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI) monthly performance is 26.57%.
Blyth, Inc. (NYSE:BTH) has 25.20% insider ownership while its institutional ownership stands at 39.00%. In last trading activity company’s stock closed at $7.64.
Akorn Inc. (NASDAQ:AKRX) failed to disclose it was lagging in integrating VersaPharm Inc. and another newly acquired subsidiary into its accounting system, artificially inflating the market price of its securities, an Akorn shareholder alleged in a securities lawsuit filed in Illinois federal court Wednesday. On last trading day Akorn, Inc. (NASDAQ:AKRX) fell -0.61% to close at $50.88. Its volatility for the week is 5.68% while volatility for the month is 3.96%. AKRX’s sales growth for past 5 years was 51.30% and its EPS growth for past 5 years was 26.30%. Akorn, Inc. (NASDAQ:AKRX) monthly performance is 16.32%.